3056440-83-3

PSMA-D5 Chemical Structure
3056440-83-3

Chemical Structure

PSMA-D5

  • CAS No.: 3056440-83-3
  • Formula:C57H80N12O24
  • Molecular Weight:1317.31

InChIKey: SLWCJKNBFXBEAA-IWWWZYECSA-N

SMILES: OC([C@@H](NC(N[C@H](C(O)=O)CCC(O)=O)=O)CCCCNC(C1=CC(C2=CC=C(C=C2)NC(CCNC(CN3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)=O)=O)=CC(C(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=O)=C1)=O)=O

Biological Activity: PSMA-D5 has a binding affinity for PSMA with a Ki of 0.21 nM and can be used for PSMA tracing after radiolabeling. PSMA-D5 ([68Ga]-labeled) contains a DOTA chelator, allowing convenient labeling with therapeutic radionuclides such as 177Lu and 225Ac. PSMA-D5 ([68Ga]-labeled) shows excellent pharmacokinetic properties, exhibiting remarkable tumor uptake in 22Rv1 tumors[1]. PSMA-D5 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).

Cat. No. Product Name Purity Description Pricing
HY-P10781
PSMA-D5 98.61% PSMA-D5 has a binding affinity for PSMA with a Ki of 0.21 nM and can be used for PSMA tracing after radiolabeling. PSMA-D5 ([68Ga]-labeled) contains a DOTA chelator, allowing convenient labeling with therapeutic radionuclides such as 177Lu and 225Ac. PSMA-D5 ([68Ga]-labeled) shows excellent pharmacokinetic properties, exhibiting remarkable tumor uptake in 22Rv1 tumors. PSMA-D5 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References